Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
about
Early trafficking and intracellular replication of Legionella longbeachaea within an ER-derived late endosome-like phagosomeChemical genetics reveals bacterial and host cell functions critical for type IV effector translocation by Legionella pneumophilaLegionella pneumophila-induced blastogenesis of murine lymphoid cells in vitroIdentification of a novel adhesion molecule involved in the virulence of Legionella pneumophila.Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomesAcid phosphatase activity in Coxiella burnetii: a possible virulence factor.Amoebae as training grounds for intracellular bacterial pathogens.Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.Legionella pneumophila entry gene rtxA is involved in virulence.Potential virulence role of the Legionella pneumophila ptsP orthologLegionnaires disease: historical perspectiveA live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge.Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisoneCaspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization.Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups.Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampinInteraction of primate alveolar macrophages and Legionella pneumophila.Analysis of the Legionella pneumophila fliI gene: intracellular growth of a defined mutant defective for flagellum biosynthesisVaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.Immunity to vacuolar pathogens: what can we learn from Legionella?Virulence factors of the family Legionellaceae.The effect of oxygen-dependent antimicrobial systems on strains of Legionella pneumophila of different virulence.Legionella pneumophila inhibits acidification of its phagosome in human monocytes.Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane proteinInteraction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intraVaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptorsLegionella pneumophila is internalized by a macropinocytotic uptake pathway controlled by the Dot/Icm system and the mouse Lgn1 locus.Legionella pneumophila lipopolysaccharide activates the classical complement pathway.Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors.Cell-mediated immunity in Legionnaires' disease.Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model.Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.Induction of tumor necrosis factor by Legionella pneumophila.Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage culturesTreatment of alveolar macrophages with cytochalasin D inhibits uptake and subsequent growth of Legionella pneumophila.Kinetics and characterization of interferon production by murine spleen cells stimulated with Legionella pneumophila antigens.
P2860
Q28288972-175293C7-4B81-4B65-AA7D-C4768ADF98F0Q28475654-CC76937A-7F09-4B9D-BADA-C5176A30F614Q30502684-55CEF27A-600B-4D79-88D3-08A355580097Q33217675-BB4166A0-61E3-4273-ACC9-D605E77B8966Q33602013-18B8589D-7AEC-4EC9-8767-D705835585D4Q33610877-0462F851-1E7C-4405-8AEB-794C232017B9Q33722169-35DE3EB4-28F5-4390-A141-7A723F46819CQ34001674-09409B26-BA57-4B94-AA3E-5995C21A3ACAQ34005732-DE41A7C5-BE41-4818-B666-F18600149D0DQ34008479-F9FC9E5A-2661-46E6-9746-10B8A28DD8B7Q34164604-0C2CD756-C129-4DE0-8A14-8C711E19B36EQ34567957-0A8E56E3-3DF2-479D-8AEE-F6FE0FECE339Q34613387-B9B3EBE0-827B-455C-8D50-84049047D9A7Q34638759-1BA6A18A-443E-4273-B463-F8793DD8A609Q34796849-83E9CEB0-013A-4C6F-A0DF-E416B8D8B7B7Q35202108-BE8D4201-4D27-4D0D-8A72-9BC66DFD1D7CQ35208609-0E4033F9-B5BE-4412-ADBD-BD8BBB36FDE1Q35550118-70701BA2-4A38-4A75-AB73-FAE1678A2735Q35820423-71D29B0B-33CF-4F9C-95BA-017D10B5BB2FQ35911170-004E5FC0-84D0-4EC8-9CCE-192B995B18E8Q36080261-5E31AEB7-D189-4905-9902-5578FDABF7F4Q36153191-2F0F6530-5464-49DB-AAFC-83EB88441FF1Q36212159-6A0062B1-0979-41E8-8A6F-F44ED869329BQ36338050-6820BE6B-E3F2-4B84-8844-D0BB6A58DC64Q36344502-AA0DF235-A0F0-436B-9043-F6BFE9F02728Q36345801-1E2C4AB9-B2D8-4646-8F55-73632EBB5D37Q36348251-60C0A82B-C8BB-4731-B092-684CB0F62B6DQ36352500-5F223795-F2E3-4912-84F2-90C5AB1E5DE7Q36356234-F6C8F7A8-1D03-4958-A424-CE9D7CF93555Q36357516-0FB16CEC-0E9E-4378-A6A3-27B30471D104Q36369590-E2A3CBD8-3889-4789-A70C-3BF14533610AQ36947494-C5BE467E-10BF-41B5-8848-D3D08A699F05Q36972878-30DA4DBC-80B6-4203-AB39-5D6F980017A9Q36989852-9392D116-672D-4373-A1CB-649A07A82575Q37004235-AB150083-A5E2-41D6-85B9-036D13007DC3Q37005867-58A02AB6-4DD0-441C-83BE-93507210B9E8Q37016444-12A8794A-A7C5-4224-8185-7F75FFF8D779Q37019569-D02655AF-178E-406F-AA6F-CC1C5362867FQ37030068-CC2C76B1-11FA-4D5F-8E5A-4C222996391FQ37033740-BF8A50F4-86E5-40D6-A3C0-EA2F03572EA9
P2860
Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Interaction of the legionnaire ...... intracellular multiplication.
@ast
Interaction of the legionnaire ...... intracellular multiplication.
@en
type
label
Interaction of the legionnaire ...... intracellular multiplication.
@ast
Interaction of the legionnaire ...... intracellular multiplication.
@en
prefLabel
Interaction of the legionnaire ...... intracellular multiplication.
@ast
Interaction of the legionnaire ...... intracellular multiplication.
@en
P2860
P356
P1476
Interaction of the legionnaire ...... intracellular multiplication.
@en
P2093
M A Horwitz
S C Silverstein
P2860
P304
P356
10.1084/JEM.153.2.398
P407
P577
1981-02-01T00:00:00Z